Active Ingredient: APOMORPHINE HYDROCHLORIDE
Proprietary Name: ONAPGO
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: 98MG/20ML (4.9MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214056
Product Number: 001
Approval Date: Feb 3, 2025
Applicant Holder Full Name: MDD US OPERATIONS LLC A SUB OF SUPERNUS PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
